Several studies have explored the link between adiponectin and DPN risk among patients with type 2 diabetes, yielding mixed results: some report an inverse association (8, 9), others find no significant correlation (10) or even a positive link (11, 12). This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.